He even cropped it like people wont go and read the full thing.
8.6 If Item 8.5 is less than 2 quarters, please provide answers to the following questions: 1. Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not? Answer: At this time the sole focus of Invion activities is the development and commercialisation of the Photosoft™ technology. The development of Photosoft™ is funded via an R&D agreement with the technology licensor, The Cho Group. Under this agreement, which was approved by Invion shareholders at the 2017 AGM, The Cho Group funds the fully burdened costs of development - including research, development and associated overhead costs - to meet pre-agreed development milestones. Funding and milestones are agreed on a quarterly basis by a Steering Committee between the parties.
IVX Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
